Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
CRISPR Therapeutics AG Banner

CRISPR Therapeutics AG

CRSP Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
-6.800m-25.828m-23.202m-68.357m-164.981m66.858M-348.865m377.661M-650.175m-153.610m
Depreciation & Amortization
38.000K127.000K925.000K3.024M3.519M4.725M9.184M17.953M24.172M19.837M
Change in Working Capital
1.534M81.368M1.781M-25.391m10.550M-48.430m33.440M26.859M19.845M-193.585m
Operating Cash Flow
-4.793m59.428M-55.310m-70.097m-96.239m56.677M-238.366m538.972M-495.741m-260.375m
Capital Expenditure
0.000-1.154m-3.016m-7.814m-2.773m-6.684m-18.358m-81.705m-37.188m-11.970m
Free Cash Flow
-4.793m58.274M-58.326m-77.911m-99.012m49.993M-256.724m457.267M-532.929m-272.345m
Debt Repayment
0.00038.239M35.010M0.0000.0000.0000.0000.0000.0000.000
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
22.000K58.494M89.061M2.608M307.053M415.019M982.289M213.267M970.000K32.721M
Common Stock Repurchased
0.0000.0000.0000.000-57.000k0.0000.0000.0000.0000.000
Net Change in Cash
584.000K155.016M159.559M-75.762m216.900M489.000M236.656M-245.524m-715.884m177.008M